Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Zoetis has added a new handheld equine blood testing device to its portfolio of diagnostics.
IDEXX Laboratories has emphasized the large addressable market for companion animal diagnostics, especially with the growing adoption of preventative testing.
US pet health specialist Better Choice is working on clinical studies on the potential of cannabidiol (CBD) products to reduce anxiety in dogs.
UK firm Austin Davis Biologics (ADB) will introduce a small redworm blood test as a diagnostic service for horses in September 2019.
The US FDA has handed a supplemental approval to Merck Animal Health for its Estrumate (cloprostenol injection) reproductive injectable for cows.
European authorities have approved MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) for the treatment of ear mites in cats.
Texas-based Volition has established Volition Veterinary Diagnostics (VVG) – a veterinary subsidiary to its human life sciences division.
Kindred Biosciences chief executive Richard Chin has said the firm is aiming to launch its monoclonal antibody candidate against canine parvovirus by the end of 2020 or early 2021.
Zomedica Pharmaceuticals has developed two new assays for its Truforma point-of-care (POC) biosensor platform.
Zoetis expects to gain approval for a new monoclonal antibody (mAb) to control pain associated with osteoarthritis in cats in 2021.
Polish start-up Bioceltix is seeking EU Good Manufacturing Practice certification to produce its mesenchymal stromal cell product candidates by the end of 2019.
Swedish business Intervacc has finalized production of its vaccine for equine strangles on a commercial scale.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.